Genmab A (GMAB) Total Liabilities: 2018-2020
Historic Total Liabilities for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $204.5 million.
- Genmab A's Total Liabilities fell 8.76% to $264.92 in Q2 2021 from the same period last year, while for Jun 2021 it was $264.92, marking a year-over-year decrease of 8.76%. This contributed to the annual value of $204.5 million for FY2020, which is 104.16% up from last year.
- Genmab A's Total Liabilities amounted to $204.5 million in FY2020, which was up 104.16% from $100.1 million recorded in FY2019.
- Genmab A's 5-year Total Liabilities high stood at $204.5 million for FY2020, and its period low was $49.4 million during FY2018.
- For the 3-year period, Genmab A's Total Liabilities averaged around $118.0 million, with its median value being $100.1 million (2019).
- Data for Genmab A's Total Liabilities shows a peak YoY spiked of 104.16% (in 2020) over the last 5 years.
- Genmab A's Total Liabilities (Yearly) stood at $49.4 million in 2018, then soared by 102.80% to $100.1 million in 2019, then soared by 104.16% to $204.5 million in 2020.